Follow
Kathryn Ellis
Kathryn Ellis
Verified email at unimelb.edu.au
Title
Cited by
Cited by
Year
A conceptual framework for research on subjective cognitive decline in preclinical Alzheimer's disease
F Jessen, RE Amariglio, M Van Boxtel, M Breteler, M Ceccaldi, G Chételat, ...
Alzheimer's & dementia 10 (6), 844-852, 2014
19602014
Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study
VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ...
The Lancet Neurology 12 (4), 357-367, 2013
18722013
Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging
CC Rowe, KA Ellis, M Rimajova, P Bourgeat, KE Pike, G Jones, J Fripp, ...
Neurobiology of aging 31 (8), 1275-1283, 2010
10372010
Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease
VL Villemagne, KE Pike, G Chételat, KA Ellis, RS Mulligan, P Bourgeat, ...
Annals of neurology 69 (1), 181-192, 2011
8932011
The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of …
KA Ellis, AI Bush, D Darby, D De Fazio, J Foster, P Hudson, ...
International psychogeriatrics 21 (4), 672-687, 2009
7282009
Blood-based protein biomarkers for diagnosis of Alzheimer disease
JD Doecke, SM Laws, NG Faux, W Wilson, SC Burnham, CP Lam, ...
Archives of neurology 69 (10), 1318-1325, 2012
4192012
Relationship between atrophy and β‐amyloid deposition in Alzheimer disease
G Chételat, VL Villemagne, P Bourgeat, KE Pike, G Jones, D Ames, ...
Annals of neurology 67 (3), 317-324, 2010
4112010
Increased risk of cognitive impairment in patients with diabetes is associated with metformin
EM Moore, AG Mander, D Ames, MA Kotowicz, RP Carne, H Brodaty, ...
Diabetes care 36 (10), 2981-2987, 2013
3942013
Implementation of subjective cognitive decline criteria in research studies
JL Molinuevo, LA Rabin, R Amariglio, R Buckley, B Dubois, KA Ellis, ...
Alzheimer's & Dementia 13 (3), 296-311, 2017
3732017
Subjective cognitive decline in older adults: an overview of self-report measures used across 19 international research studies
LA Rabin, CM Smart, PK Crane, RE Amariglio, LM Berman, M Boada, ...
Journal of Alzheimer's Disease 48 (s1), S63-S86, 2015
3712015
Australian Imaging Biomarkers and Lifestyle (AIBL) Research Group. Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer’s disease: a prospective …
VL Villemagne, S Burnham, P Bourgeat, B Brown, KA Ellis, O Salvado, ...
Lancet Neurol 12 (4), 357-367, 2013
2632013
Retinal vascular biomarkers for early detection and monitoring of Alzheimer’s disease
S Frost, Y Kanagasingam, H Sohrabi, J Vignarajan, P Bourgeat, ...
Translational psychiatry 3 (2), e233-e233, 2013
2612013
Cerebral microbleeds: a review of clinical, genetic, and neuroimaging associations
PA Yates, VL Villemagne, KA Ellis, PM Desmond, CL Masters, CC Rowe
Frontiers in neurology 4, 205, 2014
2582014
Regional dynamics of amyloid-β deposition in healthy elderly, mild cognitive impairment and Alzheimer’s disease: a voxelwise PiB–PET longitudinal study
N Villain, G Chételat, B Grassiot, P Bourgeat, G Jones, KA Ellis, D Ames, ...
Brain 135 (7), 2126-2139, 2012
2532012
β-Amyloid burden in the temporal neocortex is related to hippocampal atrophy in elderly subjects without dementia
P Bourgeat, G Chetelat, VL Villemagne, J Fripp, P Raniga, K Pike, ...
Neurology 74 (2), 121-127, 2010
2532010
Physical activity and amyloid-β plasma and brain levels: results from the Australian Imaging, Biomarkers and Lifestyle Study of Ageing
BM Brown, JJ Peiffer, K Taddei, JK Lui, SM Laws, VB Gupta, T Taddei, ...
Molecular psychiatry 18 (8), 875-881, 2013
2302013
Predicting Alzheimer disease with β‐amyloid imaging: results from the Australian imaging, biomarkers, and lifestyle study of ageing
CC Rowe, P Bourgeat, KA Ellis, B Brown, YY Lim, R Mulligan, G Jones, ...
Annals of neurology 74 (6), 905-913, 2013
2202013
Effect of amyloid on memory and non-memory decline from preclinical to clinical Alzheimer’s disease
YY Lim, P Maruff, RH Pietrzak, D Ames, KA Ellis, K Harrington, ...
Brain 137 (1), 221-231, 2014
2052014
Accelerated cortical atrophy in cognitively normal elderly with high β-amyloid deposition
G Chételat, VL Villemagne, N Villain, G Jones, KA Ellis, D Ames, ...
Neurology 78 (7), 477-484, 2012
1912012
Cross-sectional and longitudinal analysis of the relationship between Aβ deposition, cortical thickness, and memory in cognitively unimpaired individuals and in Alzheimer disease
V Doré, VL Villemagne, P Bourgeat, J Fripp, O Acosta, G Chetélat, L Zhou, ...
JAMA neurology 70 (7), 903-911, 2013
1842013
The system can't perform the operation now. Try again later.
Articles 1–20